alpha-interferon
/ Jiangxi Qingfeng Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 20, 2020
Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia
(clinicaltrials.gov)
- P=N/A; N=426; Not yet recruiting; Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.; Initiation date: Feb 2020 ➔ May 2020
Trial initiation date • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
1 to 1
Of
1
Go to page
1